Jpmorgan Chase & CO Absci Corp Transaction History
Jpmorgan Chase & CO
- $1.23 Trillion
- Q4 2024
A detailed history of Jpmorgan Chase & CO transactions in Absci Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 56,986 shares of ABSI stock, worth $284,930. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56,986
Previous 49,379
15.41%
Holding current value
$284,930
Previous $188,000
20.74%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding ABSI
# of Institutions
146Shares Held
62.5MCall Options Held
255KPut Options Held
93.6K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.27MShares$41.3 Million0.19% of portfolio
-
Redmile Group, LLC San Francisco, CA8.25MShares$41.3 Million2.06% of portfolio
-
Fred Alger Management, LLC New York, NY7.57MShares$37.8 Million0.15% of portfolio
-
Black Rock Inc. New York, NY5.34MShares$26.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.77MShares$23.9 Million0.0% of portfolio
About Absci Corp
- Ticker ABSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 92,843,504
- Market Cap $464M
- Description
- Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....